Re-thinking the functions of IgA(+) plasma cells
Ideal for GLP1 users needing nourishment without heaviness
The good news is that regulators are taking actions to address these problems
Early weight loss responders to liraglutide 3.0 mg achieved greater weight loss and regression to normoglycaemia, and reduced development of T2D at 3 years, versus early nonresponders in the SCALE obesity and prediabetes trial [abstract]
BOTTOM LINE Preliminary findings show a correlation between semaglutide/tirzepatide-type weight loss medications and lower alcohol and other drug use
Nelson DB, Rice DC, Mitchell KG, Tsao AS, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG , Roth JA, Gomez DR, Mehran RJ, Sepesi B